Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile
Advanced Prostate Cancer Consensus Conference

@apccc_lugano

APCCC facilitates discussions and debates on advanced prostate cancer diagnostic and treatment options.

ID: 2192533356

linkhttps://apccc.org calendar_today13-11-2013 16:03:59

10,10K Tweet

4,4K Takipçi

712 Takip Edilen

Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo
Advanced Prostate Cancer Consensus Conference
@apccc_lugano

3 months ago

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study out on JCO ascopubs.org/doi/10.1200/JC… In this Phase 1 trial, pasritamig—a novel bispecific antibody targeting KLK2 on

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study out on JCO ascopubs.org/doi/10.1200/JC… In this Phase 1 trial, pasritamig—a novel bispecific antibody targeting KLK2 on